Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-12

Clinical Trial Update: VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa [Phase 2]

View source ↗

Summary

Phase IIa trial of vigabatrin for post-anoxic status epilepticus has completed and results are posted. The study enrolled patients with electrographic status ep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

Sponsor: University of Florida | Conditions: Status Epilepticus, Electrographic, Coma | Phase 2 | Status: COMPLETED | Results posted: 2024-07-12